Explore what to expect now that the Hims & Hers stock price now that it has crashed hard in the past few weeks.

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Can Hims Survive Without GLP-1s? Outside of weight loss, Hims’ core business is still strong. Sales of generic treatments for hair loss and erectile dysfunction jumped 43% in 2024, reaching $1.2 ...

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...

Hims & Hers' stock has seesawed wildly this year as its weight-loss business faces new ... including treatments for hair loss, erectile dysfunction, and mental health, said shuttering Apostrophe ...

A big opportunity lately has been in helping people access GLP-1 weight ... and hair loss. And by expanding its offerings, it has reached a broader group of customers. HIMS Operating Revenue ...

Hims & Hers is well-positioned for growth. The company offers many types of treatments, including dermatology, mental health, sexual health, hair health, and weight loss, making it a one-stop ...

Hims & Hers Health (NYSE ... in the next few quarters and to gain a glimpse into whether demand remains strong even after switching patients onto other weight loss treatments, before deciding ...